Schedule 13D ownership disclosure

Stealth BioTherapeutics Corp

Security class unavailable · CUSIP: 85788D100

Event date: 2020-04-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
419,560,015
Percent of class
71.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-047482
Form type
SC 13D/A
Filer
Morningside Venture (I) Investments Ltd
CIK
CIK 1770194
Filed
Apr 16, 2020
Reporting period
Apr 10, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub